Epilepsy
The Pharmacy Times® Epilepsy Resource Center is a comprehensive resource for clinical news and expert insights on treatments for epilepsy.
Latest News
February 3rd 2023
The CBD gummy market is being fueled by the desire for alternative, natural treatment options.
Treatment Advancements to Overcome Barriers in the Management of Schizophrenia: Key Considerations for Pharmacists
1.5 Credit / Neurology, Psychiatry
View More
Novel Treatment Approaches for Alzheimer Disease: Considerations for Pharmacists Across Care Settings
1.5 Credits / Neurology
View More
Seizure Clusters: A Review of New Drug Delivery Methods and Emerging Therapy Options
0.50 Credit / Neurology
View More
Novel Non-stimulant ADHD Treatments: A Review for Pharmacists
0.75 Credit / Neurology, Psychiatry
View More
Preventing and Managing Controlled Substance Diversion Across Health Care Settings
2.0 Credits / Law
View More
The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights
View More
Treatment of ALS: Examining the Role of Current and Emerging Therapies
1.0 Credit / Neurology
View More
Managed Care Considerations for Parkinson Disease: A Focus on Recent Data and Emerging Therapies
1.0 Credit / Neurology
View More
Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs
0.75 Credit / Neurology
View More
Recognizing Rett Syndrome: Managed Care Insights on Disease Burden
1.5 Credits / Neurology, Rare Diseases
View More
Advancements in Myasthenia Gravis Treatment: Supporting Access Through Value-Based Care Models
1.5 Credits / Immunology, Neurology, Rare Diseases
View More
A Supplement to the American Journal of Managed Care: Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care
2.0 Credits / Neurology
View More
Preventing and Managing Controlled Substance Diversion Across Health Care Settings
2.0 Credits / Law
View More
Managed Care Considerations for Parkinson Disease: A Focus on Recent Data and Emerging Therapies
1.0 Credit / Neurology
View More
The Evolving Landscape of Multiple Sclerosis Treatment and Care Management Strategies
1.0 Credit / Immunology, Neurology, Rare Diseases
View More
A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacist Credit)
1.0 Credit / Neurology
View More
A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacy Technician Credit)
1.0 Credit / Neurology
View More
Novel Treatment Approaches for Alzheimer Disease: Considerations for Pharmacists Across Care Settings
1.5 Credits / Neurology
View More
Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs
0.75 Credit / Neurology
View More
Therapeutic Strategies for Bipolar Disorder: Recognizing the Intricacies in Disease Management and Considerations for Pharmacists Across Practice Settings
2.0 Credits / Neurology, Psychiatry
View More
Strategies to Improve the Management of Migraine: Clinical Updates for Pharmacists and Patient-Case Review
1.0 Credit / Neurology
View More
Recognizing Rett Syndrome: Managed Care Insights on Disease Burden
1.5 Credits / Neurology, Rare Diseases
View More
Advancements in Myasthenia Gravis Treatment: Supporting Access Through Value-Based Care Models
1.5 Credits / Immunology, Neurology, Rare Diseases
View More
Challenges of Treating Epilepsy Syndromes and Opportunities in an Expanding Therapeutic Landscape: A Managed Care Perspective
1.5 Credits / Neurology
View More
Exploring Primary Immunodeficiency Disorder Treatment: A Review of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin Therapies
1.0 Credit / Immunology, Neurology
View More
Individualizing the Management of Primary Immunodeficiency Disorders: Considerations in the Selection of Intravenous Immunoglobulin or Subcutaneous Immunoglobulin
2.0 Credits / Immunology, Neurology
View More
A Supplement to the American Journal of Managed Care: Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care
2.0 Credits / Neurology
View More
Updates in the Management of CIDP: The Pharmacist's Role in Individualizing Care, featuring a Patient Perspective
1.5 Credits / Neurology, Immunology
View More
The Evolving Landscape of Multiple Sclerosis Treatment and Care Management Strategies
1.0 Credit / Immunology, Neurology, Rare Diseases
View More
Exploring DORAs for the Treatment of Insomnia
0.75 Credit / Neurology
View More
More News
Abortion Ban Could Be Life-Threatening for Women With Neurological Conditions
July 28th 2022Researchers highlight how a lack of access to medications used to treat multiple sclerosis, migraines, and epilepsy, but not proven safe for pregnancy, threatens child-bearing aged women who live with these conditions.
Read More
FDA Grants Conditional Approval for Drug to Control Seizures in Dogs with Idiopathic Epilepsy
January 19th 2021This conditional approval is the first under the 2018 reauthorization of the FDA’s Animal Drug User Fee Act program, through which Congress granted the FDA a limited expansion of the conditional approval pathway for certain new animal drugs.
Read More
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
June 26th 2020Dravet syndrome is a life-threatening, rare, and chronic form of epilepsy and is often characterized by severe, unrelenting seizures despite medical treatment, according to the FDA press release.
Read More
The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late Development
October 29th 2019Given the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.
Read More
